Loading...

GeneDx Holdings Corp.

WGS•NASDAQ
Healthcare
Medical - Healthcare Information Services
$121.87
$-6.79(-5.28%)

GeneDx Holdings Corp. (WGS) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.0/100

Key Financials

Market Cap3.5B
P/E Ratio2473.59
EPS (TTM)$0.08
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$76.40
1 Month$74.73
3 Months$136.84
1 Year Target$0.63

WGS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GeneDx Holdings Corp. (WGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2473.59 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.80%
5-Day Change
24.27%
1-Month Change
3.30%
3-Month Change
3.62%
6-Month Change
68.40%
Year-to-Date (YTD) Change
16.31%
1-Year Change
701.21%
3-Year Change
7.54%
5-Year Change
-71.36%
All-Time (Max) Change
-71.36%

Contact Information

http://www.genedx.com
800 298 6470
North Tower, Stamford, CT, 06902

Company Facts

1,000 Employees
IPO DateNov 4, 2020
CountryUS
Actively Trading

Frequently Asked Questions

;